As Cancer Takes Her Life, JFK Descendant Opposes Cousin's Health Policies
- JFK's granddaughter Tatiana Schlossberg revealed terminal AML diagnosis, criticizing cousin RFK Jr.'s cuts to mRNA vaccine research funding critical for cancer therapies. - RFK Jr.'s HHS nomination faces scrutiny as his anti-vaccine policies align with CDC's revised guidelines, raising concerns about public health trust and research equity. - OCRA's new policy center and interactive map aim to accelerate cancer research access, responding to Schlossberg's advocacy for equitable clinical trial resources.
Tatiana Schlossberg, the granddaughter of John F. Kennedy, shared in a heartfelt essay for The New Yorker that she has been diagnosed with terminal cancer, while also condemning her cousin Robert F. Kennedy Jr. for policy choices she believes endanger cancer patients. At 34, Schlossberg revealed she was found to have acute myeloid leukemia with an uncommon mutation in May 2024, shortly after her second child was born. She described undergoing chemotherapy, two stem cell transplants, and participating in clinical trials, and recounted a recent conversation with her doctor who told her, "he could keep me alive for a year, maybe"
Schlossberg's criticism is directed at RFK Jr., who has become a notable figure in health policy and was recently nominated by President Donald Trump for Health and Human Services secretary. She called attention to RFK Jr.'s move to eliminate nearly $500 million in federal support for mRNA vaccine research—a technology she believes could be adapted to treat some cancers
This dispute highlights larger issues in American health policy, especially regarding funding for research and regulatory choices. The Ovarian Cancer Research Alliance (OCRA), which has long advocated for more federal funding, has recently established a Center for Public Policy to strengthen its advocacy. The center’s mission is to speed up research, broaden access to clinical trials, and enhance drug availability, echoing Schlossberg’s concerns about how resources are distributed
RFK Jr.'s role in shaping public health policy has also led to changes in vaccine recommendations. The CDC has recently updated its guidance on childhood vaccinations, moving away from universal recommendations for all age groups and instead encouraging more personalized discussions
Schlossberg’s openness about her diagnosis has reignited discussions about how politics and healthcare intersect. "For my whole life, I have tried to be good," she reflected, noting that her illness has brought "a new tragedy" to her family
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ethereum Updates: DeFi's Vulnerability Exposed—Centralized DNS Attacks Lead to User Asset Loss
- Aerodrome and Velodrome DEXs suffered DNS hijack attacks, redirecting users to phishing sites via compromised registrars like Box Domains. - Attackers exploited centralized domain vulnerabilities to steal ETH, NFTs, and stablecoins, mirroring a 2023 incident that caused $100K+ losses. - Platforms urged users to bypass main domains and use decentralized mirrors, highlighting ongoing risks in DeFi's off-chain infrastructure. - Experts recommend DNSSEC and ENS adoption as solutions, while Dromos Labs plans
Ethereum Updates Today: Mutuum Finance Leads the Next Crypto Era with Utility-Focused DeFi Advancements
- Mutuum Finance (MUTM) leads crypto's utility-driven shift, raising $18.8M in Phase 6 presale at $0.035. - Its hybrid P2C/P2P lending protocol optimizes DeFi liquidity, addressing 83-95% idle capital inefficiencies. - Certified by 90/100 audit score and 2025 testnet launch, MUTM targets $2.50 by 2030 (7,000% gain). - Phased pricing model and 45.5% early allocation drive urgency, outpacing memecoins with structural growth. - Analysts position MUTM as Ethereum alternative, prioritizing real-world adoption o
Solana (SOL) Price Forecast for Q1 2026: Are Network Improvements and Ecosystem Expansion Enough to Support an Optimistic Perspective?
- Solana's 2025 Firedancer/Alpenglow upgrades enhance scalability, positioning it as a top Layer-1 competitor with faster consensus and lower costs. - Strategic partnerships with Coinbase and PrimeXBT boost institutional adoption, while $3B+ ecosystem revenue highlights DeFi and meme coin growth. - Anticipated spot ETF approvals and Fed rate cuts could inject $6B+ liquidity, potentially pushing SOL toward $279 in Q1 2026 if upgrades gain traction. - Risks include regulatory scrutiny of key projects and unr
The Federal Reserve's Change in Policy and Its Unexpected Effects on the Solana Ecosystem
- Fed's 2025 policy shift ends QT, cuts rates 0.25%, triggering global market shifts and Solana's DeFi ecosystem repositioning. - Solana leverages Fed liquidity injections through Coinbase's Vector acquisition and Wormhole's Sunrise gateway to boost DeFi scalability. - Network TVL drops 4.7% amid macro uncertainty, while SIMD-0411 proposal reduces Solana's issuance by $2.9B by 2029 to reinforce scarcity. - Fed's $72.35B liquidity injection correlates with Solana's $3.65B daily trading volume spike, yet reg
Trending news
MoreCrypto prices
More
